agilon health, inc. (AGL) stock
AGLNYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
$90.53−24.67 (-21.41%)
Close on Nov 18, 2026Market cap $1.52BP/E –Yield –
agilon health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
agilon health's revenue for the twelve months ending Jun 30, 2026 was $5.92B, up 0.3% year over year. For fiscal 2025 it was $5.93B, down 2.1% from the year before. The highest annual figure on record is $6.06B in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.93B | -2.1% |
| FY2024 | Dec 31, 2024 | $6.06B | +40.4% |
| FY2023 | Dec 31, 2023 | $4.32B | +80.7% |
| FY2022 | Dec 31, 2022 | $2.39B | +57.0% |
| FY2021 | Dec 31, 2021 | $1.52B | +24.9% |
| FY2020 | Dec 31, 2020 | $1.22B | +53.4% |
| FY2019 | Dec 31, 2019 | $794.41M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.49B | +7.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.42B | -7.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.57B | +3.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.44B | -1.1% |
| Q2 FY2025 | Jun 30, 2025 | $1.39B | -5.9% |
| Q1 FY2025 | Mar 31, 2025 | $1.53B | -4.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.52B | +44.2% |
| Q3 FY2024 | Sep 30, 2024 | $1.45B | +27.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.48B | +38.7% |
| Q1 FY2024 | Mar 31, 2024 | $1.60B | +52.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.06B | +185.6% |
| Q3 FY2023 | Sep 30, 2023 | $1.14B | +63.6% |
| Q2 FY2023 | Jun 30, 2023 | $1.07B | +59.5% |
| Q1 FY2023 | Mar 31, 2023 | $1.05B | +61.3% |
| Q4 FY2022 | Dec 31, 2022 | $369.78M | +145.2% |
| Q3 FY2022 | Sep 30, 2022 | $694.86M | +51.5% |
| Q2 FY2022 | Jun 30, 2022 | $670.13M | +34.3% |
| Q1 FY2022 | Mar 31, 2022 | $653.45M | +58.2% |
| Q4 FY2021 | Dec 31, 2021 | $150.82M | -53.0% |
| Q3 FY2021 | Sep 30, 2021 | $458.61M | +46.7% |
| Q2 FY2021 | Jun 30, 2021 | $498.96M | +69.9% |
| Q1 FY2021 | Mar 31, 2021 | $413.10M | +41.9% |
| Q4 FY2020 | Dec 31, 2020 | $321.01M | – |
| Q3 FY2020 | Sep 30, 2020 | $312.68M | – |
| Q2 FY2020 | Jun 30, 2020 | $293.59M | – |
| Q1 FY2020 | Mar 31, 2020 | $291.05M | – |
See a number that looks wrong?